Eli Lil­ly claims suc­cess in a new JAK in­di­ca­tion: hair loss

Over the last decade, drug­mak­ers have proven JAK in­hibitors can treat a smat­ter­ing of im­mune-re­lat­ed dis­eases rang­ing from rheuma­toid arthri­tis to Covid-19. Now Eli Lil­ly …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.